These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26708059)
1. Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity. Hermawan A; Wagner E; Roidl A Oncol Rep; 2016 Mar; 35(3):1732-40. PubMed ID: 26708059 [TBL] [Abstract][Full Text] [Related]
2. Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells. Zhou Q; Ye M; Lu Y; Zhang H; Chen Q; Huang S; Su S PLoS One; 2015; 10(8):e0136694. PubMed ID: 26305906 [TBL] [Abstract][Full Text] [Related]
3. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. Rigalli JP; Tocchetti GN; Arana MR; Villanueva SS; Catania VA; Theile D; Ruiz ML; Weiss J Cancer Lett; 2016 Jun; 376(1):165-72. PubMed ID: 27033456 [TBL] [Abstract][Full Text] [Related]
4. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells]. Zhang YH; Li G; Yu J; Xu MS; Liu ZX Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044 [TBL] [Abstract][Full Text] [Related]
5. Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin. Kim KY; Kim SH; Yu SN; Park SK; Choi HD; Yu HS; Ji JH; Seo YK; Ahn SC Mol Med Rep; 2015 Aug; 12(2):1898-904. PubMed ID: 25892525 [TBL] [Abstract][Full Text] [Related]
6. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics. Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502 [TBL] [Abstract][Full Text] [Related]
7. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation. Yakisich JS; Venkatadri R; Azad N; Iyer AKV J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932 [TBL] [Abstract][Full Text] [Related]
8. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression. Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939 [TBL] [Abstract][Full Text] [Related]
9. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Qiu JG; Zhang YJ; Li Y; Zhao JM; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Shi Z Oncotarget; 2015 Jun; 6(17):15494-509. PubMed ID: 25915534 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells. Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11. Mishra MN; Vangara KK; Palakurthi S Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines. Jandu H; Aluzaite K; Fogh L; Thrane SW; Noer JB; Proszek J; Do KN; Hansen SN; Damsgaard B; Nielsen SL; Stougaard M; Knudsen BR; Moreira J; Hamerlik P; Gajjar M; Smid M; Martens J; Foekens J; Pommier Y; Brünner N; Schrohl AS; Stenvang J BMC Cancer; 2016 Jan; 16():34. PubMed ID: 26801902 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697 [TBL] [Abstract][Full Text] [Related]
14. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report. Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036 [TBL] [Abstract][Full Text] [Related]
15. Phorbol ester TPA modulates chemoresistance in the drug sensitive breast cancer cell line MCF-7 by inducing expression of drug efflux transporter ABCG2. Kalalinia F; Elahian F; Hassani M; Kasaeeian J; Behravan J Asian Pac J Cancer Prev; 2012; 13(6):2979-84. PubMed ID: 22938493 [TBL] [Abstract][Full Text] [Related]
16. Quantification of the expression of multidrug resistance-related genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres. Laurand A; Laroche-Clary A; Larrue A; Huet S; Soma E; Bonnet J; Robert J Anticancer Res; 2004; 24(6):3781-8. PubMed ID: 15736412 [TBL] [Abstract][Full Text] [Related]
17. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536 [TBL] [Abstract][Full Text] [Related]
18. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
19. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance. Tsou SH; Chen TM; Hsiao HT; Chen YH PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866 [TBL] [Abstract][Full Text] [Related]
20. Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway. Zhang ZM; Wu JF; Luo QC; Liu QF; Wu QW; Ye GD; She HQ; Li BA Oncogene; 2016 Sep; 35(36):4787-97. PubMed ID: 26876203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]